rs4135386

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001904.4(CTNNB1):​c.2320C>T​(p.Leu774Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00513 in 1,614,094 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 21 hom. )

Consequence

CTNNB1
NM_001904.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.51

Publications

6 publications found
Variant links:
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • severe intellectual disability-progressive spastic diplegia syndrome
    Inheritance: Unknown, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • exudative vitreoretinopathy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 3-41239316-C-T is Benign according to our data. Variant chr3-41239316-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.51 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00374 (570/152330) while in subpopulation NFE AF = 0.00547 (372/68034). AF 95% confidence interval is 0.00501. There are 2 homozygotes in GnomAd4. There are 298 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 570 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001904.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNB1
NM_001904.4
MANE Select
c.2320C>Tp.Leu774Leu
synonymous
Exon 15 of 15NP_001895.1P35222
CTNNB1
NM_001098209.2
c.2320C>Tp.Leu774Leu
synonymous
Exon 15 of 16NP_001091679.1P35222
CTNNB1
NM_001098210.2
c.2320C>Tp.Leu774Leu
synonymous
Exon 15 of 16NP_001091680.1P35222

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNB1
ENST00000349496.11
TSL:1 MANE Select
c.2320C>Tp.Leu774Leu
synonymous
Exon 15 of 15ENSP00000344456.5P35222
CTNNB1
ENST00000396183.7
TSL:1
c.2320C>Tp.Leu774Leu
synonymous
Exon 15 of 16ENSP00000379486.3P35222
CTNNB1
ENST00000396185.8
TSL:1
c.2320C>Tp.Leu774Leu
synonymous
Exon 15 of 16ENSP00000379488.3P35222

Frequencies

GnomAD3 genomes
AF:
0.00374
AC:
570
AN:
152212
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00504
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00584
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00547
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00382
AC:
958
AN:
250610
AF XY:
0.00376
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00287
Gnomad ASJ exome
AF:
0.000596
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00731
Gnomad NFE exome
AF:
0.00571
Gnomad OTH exome
AF:
0.00490
GnomAD4 exome
AF:
0.00528
AC:
7713
AN:
1461764
Hom.:
21
Cov.:
31
AF XY:
0.00504
AC XY:
3664
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.000806
AC:
27
AN:
33480
American (AMR)
AF:
0.00280
AC:
125
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.000880
AC:
23
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39688
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86250
European-Finnish (FIN)
AF:
0.00863
AC:
461
AN:
53388
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.00608
AC:
6763
AN:
1111960
Other (OTH)
AF:
0.00502
AC:
303
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
413
826
1238
1651
2064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00374
AC:
570
AN:
152330
Hom.:
2
Cov.:
32
AF XY:
0.00400
AC XY:
298
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41568
American (AMR)
AF:
0.00503
AC:
77
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00584
AC:
62
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00547
AC:
372
AN:
68034
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00438
Hom.:
1
Bravo
AF:
0.00339
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00485
EpiControl
AF:
0.00534

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Medulloblastoma;C0206711:Pilomatrixoma;C0346629:Colorectal cancer;C0919267:Ovarian neoplasm;C2239176:Hepatocellular carcinoma;C3554449:Severe intellectual disability-progressive spastic diplegia syndrome;C4539767:Exudative vitreoretinopathy 7 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
8.0
DANN
Benign
0.73
PhyloP100
2.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4135386; hg19: chr3-41280807; COSMIC: COSV62690664; COSMIC: COSV62690664; API